ArticleSAGE open medical case reports2022

Successful peficitinib addition on anti-MDA5 antibody-positive dermatomyositis refractory to triple therapy and glucocorticoid reduction.

Yuki Oba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.